beectd.com

What It Is

beeCTD is an online eCTD / NeeS submission lifecycle management tool from Altamira Softworks, built for pharmaceutical companies and government regulatory agencies. The official website describes it as a web-based modular tool and states that it is already used by EU government regulators. The product focuses on viewing, validating, and compiling drug registration submission packages, making it a highly vertical regulatory-affairs SaaS product.

Core Features and Collaboration Permissions

Its core modules include Reader, Validator, and Compiler. Reader is used to view the full dossier lifecycle, including eCTD and NeeS sequences. It supports baseline submissions when migrating from NeeS to eCTD, automatic metadata import and editing, grouped dossiers, tree structures, file status, public/private notes, file previews, and full-text search across filenames and PDF content. Validator supports drag-and-drop uploads in the browser, batch uploads, automatic pairing of sequences from the same dossier, automatic recognition of eCTD or NeeS followed by the appropriate validation process, validation against the latest or older standards, and PDF export with error explanations and suggested fixes. With the required permissions, administrators can rerun validation or manually mark a submission as passed. Compiler supports compiling documents into an eCTD-compliant format, either as a self-service workflow or as an on-demand compilation service provided by the vendor.

Pricing, Deployment, and Security

The official website does not disclose plans, pricing, a free tier, or trial information; buyers need to contact sales or book a demo. Deployment details are relatively clear: the product is designed to run in the cloud, and the validator is web based, requiring no software installation and not interfering with existing infrastructure. Self-hosting is not mentioned. Security and compliance information mainly comes from the website terms: personal data is stored on the operator’s servers, physical security is handled by subcontractors, and Hetzner Online GmbH is specifically mentioned, with data centers compliant with ISO 27001. Access to personal data follows the principle of necessity. Product-level encryption, audit logs, backups, SLA, and similar details are not specified.

Pros, Cons, and Best-Fit Users

Its strengths are a very focused use case, covering eCTD / NeeS viewing, validation, compilation, and lifecycle management. Validation standards are kept up to date while older versions are also supported, and the product has usage background on both the regulator and pharmaceutical-company sides. Its drawbacks are opaque commercial terms, no visible API, developer documentation, or business-system integration capabilities, and fairly basic security disclosures. It is better suited to regulatory affairs teams, drug registration departments, regulators, and related consulting firms, rather than general-purpose enterprise document management.

China Access and Alternatives

The official website does not provide information on mainland China access, RMB payments, invoices, local support, or a Chinese interface, so china access can only be assessed as unknown. For long-term use in China, it is advisable to first test network connectivity, upload speed, cross-border data transfer requirements, and compliance requirements for drug registration materials, and to confirm contract terms, data storage locations, and support time zones with the vendor. No alternatives are provided in the source text; selection should be conducted separately based on capabilities such as eCTD validation, compilation, and submission lifecycle management.